Natural Killer Cells Modulation in Hematological Malignancies
Céline Baier(Inserm), Régis Costello(Inserm), Pascal Rihet(Aix-Marseille Université), Aurore Fino(Inserm), Brigitte Kahn‐Perlès(Inserm), Laure Farnault(Aix-Marseille Université), Carole Sanchez(University of Liège)
Cited by 39
Related Papers
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
|Journal of the American Heart Association|2020|298
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
|Blood|2021|157
Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors
|Blood Cancer Journal|2016|74
High incidence of atrial fibrillation in patients treated with ibrutinib
|Open Heart|2019|72
Hematological Malignancies Escape from NK Cell Innate Immune Surveillance: Mechanisms and Therapeutic Implications
|Clinical and Developmental Immunology|2012|60